The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?

Autor: Klawiter EC, Cross AH, Naismith RT, Klawiter, Eric C, Cross, Anne H, Naismith, Robert T
Zdroj: Neurology; 9/22/2009, Vol. 73 Issue 12, p984-990, 7p
Databáze: Supplemental Index